07FE44F21FD2C9DD8725822E00712C15 Hearing Summary CLICS/CLICS2018A/commsumm.nsf PUBLICBILL SUMMARY For SB18-022SENATE COMMITTEE ON HEALTH & HUMAN SERVICESDate Feb 8, 2018 Location SCR 354 SB18-022 - Amended, referred to the Committee of the Whole Attachment Tag File Name Attachment A http://www2.leg.state.co.us/CLICS/CLICS2018A/commsumm.nsf/0/E23B22611B91...$File/18SenateHealth0208AttachA.pdf?OpenElement 18SenateHealth0208AttachA.pdf 01:36:09 PM Senator Aguilar and Senator Tate, co-prime sponsors, presented Senate Bill 18-022. The bill limits to a seven-day supply, the number of opioid pills that a health care provider including physicians, physician assistants, advanced practice nurses, dentists, optometrists, podiatrists, and veterinarians, may prescribe to a patient. At the discretion of the provider, the prescription may include one refill for an additional seven-day supply. With certain exceptions, the bill also requires health care providers or their designees, to query the Prescription Drug Monitoring Program (PDMP) prior to prescribing the first refill prescription for an opioid. The bill includes a number of exceptions to the seven-day limitation and allows for a health care provider to electronically prescribe opioids. When initially querying the PDMP, each health care provider or designee is required to identify his or her area of health care specialty or practice. The bill also requires the Department of Public Health and Environment to report its findings to the General Assembly from studies conducted on PDMP integration methods and health care provider report cards. The department is also required to provide the findings to the Center for Research Into Substance Use Disorder Prevention, Treatment, and Recovery Support Strategies at the University of Colorado Health Sciences Center. The center is required to use the information to provide voluntary training for health care providers in targeted areas. Amendment L.005 was distributed to the committee (Attachment A). 01:40:43 PM Dr. Robert Valuck, Colorado Consortium for Prescription Drug Abuse Prevention, testified in support of the bill. Dr. Valuck responded to questions from the committee. 01:53:25 PM Dr. J. Scott Bainbridge, Colorado Pain Society, testified in support of the bill. Dr. Bainbridge responded to questions from the committee. 01:58:35 PM Dr. Stephanie Gold, Colorado Academy of Family Physicians, testified in support of the bill. Dr. Gold responded to questions from the committee. 02:02:57 PM Dr. Don Stader, Colorado Medical Society, testified in support of the bill and responded to questions from the committee. Committee discussion followed. 02:13:12 PM Kelly Tobin, Colorado Cross-Disability Coalition (CCDC), testified in support of the bill. 02:20:28 PM Jennifer Remington, CCDC, testified in support of the bill. Senator Aguilar commented on issues brought up during previous testimony. 02:26:03 PM Committee questions and comments followed. 02:27:50 PM Committee discussion continued. 02:31:24 PM Edie Sonn, Pinnacol Assurance, testified in support of the bill. 02:35:53 PM Jackie Zheleznyak, Denver Health, testified in support of the bill. 02:38:52 PM Jennifer Goodrum, Colorado Dental Association (CDA), testified in a neutral position on the bill and discussed CDA's concerns about amendment L.005 (Attachment A). Ms. Goodrum responded to questions from the committee. Committee comments followed. 02:51:24 PM Committee discussion ensued. 02:54:18 PM Lindsey Myers, Colorado Department of Public Health and Environment, testified in support of the bill. 02:57:48 PM Senator Tate made closing comments. 03:02:45 PM Motion Adopt amendment L.005 (Attachment A). Moved Aguilar Seconded Aguilar Crowder Kefalas Martinez Humenik Excused Smallwood YES: 0 NO: 0 EXC: 1 ABS: 0 FINAL ACTION: Pass Without Objection 03:05:25 PM Motion Refer Senate Bill 18-022, as amended, to the Committee of the Whole. Moved Aguilar Seconded Aguilar Yes Crowder Yes Kefalas Yes Martinez Humenik Yes Smallwood Yes Final YES: 5 NO: 0 EXC: 0 ABS: 0 FINAL ACTION: PASS